Company news

ADMA Biologics Inc news in 2019

ADMA Biologics Inc's news releases, calls and decks from 2019, newest first.

View company

ADMA Biologics Added to NASDAQ Biotechnology Index

December 16, 2019

ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference

November 12, 2019

ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress

November 5, 2019

ADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association

November 3, 2019

ADMA Biologics Named Company of the Year by BioFlorida

October 21, 2019

ADMA Biologics Announces First Commercial Sales of ASCENIV™

October 20, 2019

ADMA Biologics Announces Publication of an Article Describing the Manufacturing Process Optimization for its Commercial Products BIVIGAM® and ASCENIV™ in the Peer Reviewed Journal Immunotherapy

October 16, 2019

ADMA Biologics Announces Data Presented at IDWeek 2019

October 6, 2019

ADMA Biologics Announces Poster Presentation at IDWeek 2019

October 2, 2019

ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference

September 22, 2019

ADMA Receives Department of Health and Human Services U.S. License

April 1, 2019

FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin

March 31, 2019

Decks in 2019